标题:Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma
作者:Gong N.; Zhu W.; Xu R.; Teng Z.; Deng C.; Zhou H.; Xia M.; Zhao M.
作者机构:[Gong, N] Department of Otolaryngology, Shandong Provincial Hospital Affiliated to Shandong University, China;[ Zhu, W] Department of Pathology, Shand 更多
通讯作者:Zhao, M(zhaomqsd@163.com)
通讯作者地址:[Zhao, M] Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Weiqi Road, China;
来源:Biochemical and Biophysical Research Communications
出版年:2020
DOI:10.1016/j.bbrc.2020.02.058
关键词:Ker-exo; Middle ear cholesteatoma; miRNA-17; Osteoclast differentiation; RANKL
摘要:The occurrence and development of osteoclasts can directly affect the severity of bone destruction in middle ear cholesteatoma. At the same time, cell communication between keratinocytes and fibroblasts can stimulate osteoclast differentiation. However, the molecular mechanism of osteoclast differentiation in cholesteatoma is still poorly understood. In this study, we try to isolate the exosomes of keratinocytes from patients with middle ear cholesteatoma, and explore the effects of keratinocyte-derived exosomes (Ker-Exo) on osteoclast differentiation by co-culturing Ker-Exo with fibroblasts and osteoclast precursor cells. As a result, we confirmed that Ker-Exo primed fibroblasts can up-regulate the expression of RANKL and promote osteoclast differentiation. We revealed that the effect of Ker-Exo depened on its miRNA-17 conponent. Analysis confirmed that miRNA-17 was down-regulated in Ker-Exo, and they can increase RANKL level in fibroblasts, thus promoting the differentiation of osteoclasts. In conclusions, we provide evidence that exosomes miRNA-17 secreted by keratinocytes in patients with middle ear cholesteatoma can up-regulate the expression of RANKL in fibroblasts and induce osteoclast differentiation. © 2020 Elsevier Inc.
收录类别:SCOPUS
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079864989&doi=10.1016%2fj.bbrc.2020.02.058&partnerID=40&md5=68ac6d413d1c01d46e1280255f94f0bb
TOP